Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,039 public trials 566 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

High Dose Carfilzomib for Newly Diagnosed Myeloma

NCT02937571

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
View Trial Details
Completed

Non-invasive Diagnostics and Monitoring of MRD and Clonal Evolution in Waldenström's Macroglobulinemia and in IgM-MGUS

NCT03521596

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations
  • Divisione di Ematologia Ospedale Niguarda Milan, MI, Italy
  • SOS Ematologia Ospedale C. Massaia Asti, Italy
  • IRCCS Istituto Tumori Giovanni Paolo II - UOC Ematologia Bari, Italy
  • AOU Università degli Studi della Campania Luigi Vanvitelli Naples, Italy
View all 14 locations
View Trial Details
Completed

Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT02199665

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Mayo Clinic (AZ) Scottsdale, Arizona, United States
  • University of Chicago Chicago, Illinois, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Wayne State University Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Completed

An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma

NCT01592370

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations
  • Local Institution - 0035 Clovis, California, United States
  • Division Of Hematology & Oncology Ctr. For Health Sciences Los Angeles, California, United States
  • Local Institution - 0012 Los Angeles, California, United States
  • Local Institution - 0017 Aurora, Colorado, United States
View all 43 locations
View Trial Details
Completed

A Study of Colesevelam for Lenalidomide-Associated Diarrhea

NCT03767257

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Diarrhea, +16 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Completed

Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma

NCT02252172

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Birmingham, Alabama, United States
  • Mobile, Alabama, United States
  • Glendale, Arizona, United States
  • Berkeley, California, United States
View all 206 locations
View Trial Details

Related conditions